Beruflich Dokumente
Kultur Dokumente
S. Saengamnatdej, Ph.D.
October 2008
Features
• The virulence differs among serotypes and between different strains of the same
serotype.
Swine diseases
Occupational disease
Human diseases
Physicians around the world should be aware of the possibility of S. suis-associated STSS
when they see patients with unexplained sepsis who had been in contact with pigs.
Epidemiology
• Zoonosis
• Unlikely human-to-human transmission without close contact with materials (blood)
• No obvious seasonal, but two Chinese outbreaks occurred in summer.
• first human (Denmark) case 1968
• Three outbreaks in China; in 1998, 1999, and 2005.
• spread worldwide, but three countries are comprised of almost 90% (China 69%,
Thailand 11.5% [with highest mortality rate26%] and Netherlands 8.3%)
• 2005 outbreak in china: 204 infected and 38 deaths
• Total 409 cases with 73 deaths (2007 review)
• Capsular serotypes: 35 types (1-34 and ½), but types 32 and 34 proven to be S.
orisratti.
• In most countries, capsular type 2 is currently the cause of most S. suis infections,
whereas in Denmark and Finland, capsular type 7 appears to be most prevalent.
Case report
• Taiwan Case 1 (38): fever, chill, headache, hearing impairment, acute OM, CSF
culture yielded S. suis. a bank clerk, no pig contact. (tx: ceftriaxone, then PenG)
• Taiwan case 2 (52): fever, nausea, headache, vomiting, neck stiffness, photophobia,
(tx: Amp + Ceftriaxone), blood culture: S. suis, sterile CSF, Skin itching (pen allergic →
ceftriaxone alone x14d), a pultry seller with a pig farm near her home.
• Taiwan case 3 (61), diarrhea, abd pain, consciousness change
Lab identification
• Culture
• rapid growth
• small colony (0.5-1.0 mm)
• gray-whitish colonies, or grayish or transparent and slightly mucoid.
• alpha-hemolysis (trypticase soy agar + 5% SRBC) 5%CO2, 35°C
• type 2 produces beta-hemolysis on horse blood agar plates.
• catalase-negative
• gram-positive cocci
• No growth in 6.5% NaCl media
• Other techniques
• immunocapture
• fluorescent antibody techniques
• whole-cell antigen-based indirect ELISA, and
• purified capsular polysaccharide antigen-based indirect ELISA.